Prevalence of genitourinary syndrome of menopause and impact on sexuality, in Quindío (Colombia), 2013-2016
DOI:
https://doi.org/10.18597/rcog.3111Keywords:
Atrophy, dyspareunia, menopause, prevalence, lower urinary tract symptomsAbstract
Objective:To determine the prevalence of the genitourinary syndrome of menopause in a population of sexually active women 40 years of age or older.
Materials and methods: Descriptive cross-sectional study which included women diagnosed with menopause, sexually active over the past six weeks and residents of the Department of Quindío in the coffee growing Andean region of Colombia. Excluded were women with surgical menopause, illiterate, and with mental disorders or deficit. The study was conducted in a private referral centre between 2013 and 2016. Consecutive convenience sampling was used. Measured variables included demographics, vulvovaginal and lower urinary tract symptoms associated with the genitourinary syndrome of menopause, and the presence of global sexual dysfunction, using the Female Sexual Function Index validated in Spanish and by type of dysfunction. A descriptive analysis of the data was performed applying absolute and relative frequency measurements. Prevalence was calculated as the number of women with genitourinary syndrome of menopause/number of women interviewed.
Results: Of a total of 597 women selected to participate in the study, 558 (93.46%) were included in the final analysis. The prevalence of the genitourinary syndrome of menopause was 51.61% (62.88% in women over 55 years of age and 39.32% in women under 55). The prevalence of sexual dysfunction in the study group was 67.2%. Findings included altered desire (67.2%), arousal (45.16%), orgasm (44.08%), and lubrication (32.25%), as well as pain during intercourse (13.97%).
Conclusion: A high prevalence of the genitourinary syndrome of menopause and sexual dysfunction was found in the study population. Population studies are required in order to determine the size of the problem in the Latin American region.
Author Biography
Franklin José Espitia De La Hoz
Servicio de Ginecología y Medicina Materno Fetal, Clínica La Sagrada Familia, Armenia (Colombia).
References
Portman DJ, Gass ML. Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: New terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and the North American Menopause Society. Menopause. 2014;21:1063-8. https://doi.org/10.1097/GME.0000000000000329
Gandhi J, Chen A, Dagur G, Suh Y, Smith N, Cali B, et al. Genitourinary syndrome of menopause: An overview of clinical manifestations, pathophysiology, etiology, evaluation and management. Am J Obstet Gynecol. 2016;215:704-11. https://doi.org/10.1016/j.ajog.2016.07.045
Espitia-De La Hoz FJ, Orozco Gallego H. Abordaje diagnóstico y terapéutico del síndrome genitourinario en la menopausia; actualización. Rev Med UCR. 2017;117:67-84. https://doi.org/10.15517/rmucr.v11i2.34580
Nappi RE, Lachowsky M. Menopause and sexuality: Prevalence of symptoms and impact on quality of life. Maturitas. 2009;63:138-41. https://doi.org/10.1016/j.maturitas.2009.03.021
Cumming GP, Currie HD, Moncur R, Lee AJ. Web-based survey on the effect of menopause on women’s libido in a computer-literate population. Menopause Int. 2009;15:8-12. https://doi.org/10.1258/mi.2009.009001
Espitia-De La Hoz FJ. Prevalence and characterization of sexual dysfunctions in women, in 12 Colombian cities, 2009-2016. Rev Colomb Obstet Ginecol. 2018;69:9-21. https://doi.org/10.18597/rcog.3035
Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26:191-208. https://doi.org/10.1080/009262300278597
Vallejo-Medina P, Pérez-Durán C, Saavedra-Roa A. Translation, adaptation, and preliminary validation of the female sexual function index into Spanish (Colombia). Arch Sex Behav. 2017;1-14. https://doi.org/10.1007/s10508-017-0976-7
Palacios S, Mejía A, Neyro JL. Treatment of the genitourinary syndrome of menopause. Climacteric. 2015;18:23-9. https://doi.org/10.3109/13697137.2015.1079100
Golmakani N, Parnan Emamverdikhan A, Zarifian A, Sajadi Tabassi SA, Hassanzadeh M. Vitamin E as alternative local treatment in genitourinary syndrome of menopause: A randomized controlled trial. Int Urogynecol J. 2018. https://doi.org/10.1007/s00192-018-3698-z
Portman D, Palacios S, Nappi RE, Mueck AO. Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: A randomised, placebo-controlled, phase III trial. Maturitas. 2014;78:91-8. https://doi.org/10.1016/j.maturitas.2014.02.015
Bruyniks N, Nappi RE, Castelo-Branco C, de Villiers TJ, Simon J. Effect of ospemifene on moderate or severe symptoms of vulvar and vaginal atrophy. Climacteric. 2016;19:60-5. https://doi.org/10.3109/13697137.2015.1113517
Rabley A, O’Shea T, Terry R, Byun S, Louis Moy M. Laser Therapy for Genitourinary Syndrome of Menopause. Curr Urol Rep. 2018;19:83. https://doi.org/10.1007/s11934-018-0831-y
Espitia-De La Hoz FJ. Prevalencia de disfunción sexual en mujeres del Eje Cafetero. Rev Cienc Biomed. 2016;7:15-23.
Nappi RE, Kingsberg S, Maamari R, Simon J. The CLOSER (CLarifying Vaginal Atrophy’s Impact On SEx and Relationships) survey: Implications of vaginal discomfort in postmenopausal women and in male partners. J Sex Med. 2013;10:2232-41. https://doi.org/10.1111/jsm.12235
Moral E, Delgado JL, Carmona F, Caballero B, Guillán C, González PM, et al., as the writing group of the GENISSE study. Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study. Climacteric. 2018;21:167-73. https://doi.org/10.1080/13697137.2017.1421921
Geng L, Zheng Y, Zhou Y, Li C, Tao M. The prevalence and determinants of genitourinar y syndrome of menopause in Chinese mid-life women: A single center study. Climacteric. 2018;21:478-82. https://doi.org/10.1080/13697137.2018.1458832
Nappi RE, Kokot-Kierepa M. Women’s voices in the menopause: Results from an international survey on vaginal atrophy. Maturitas. 2010;67:233-8. https://doi.org/10.1016/j.maturitas.2010.08.001
Chua Y, Limpaphayom KK, Cheng B, Ho CM, Sumapradja K, Altomare C, et al. Genitourinary syndrome of menopause in five Asian countries: Results from the Pan-Asian REVIVE survey. Climacteric. 2017;20:367-73. https://doi.org/10.1080/13697137.2017.1315091
van Geelen JM, van de Weijer PH, Arnolds HT. Urogenital symptoms and resulting discomfort in non-institutionalized Dutch women aged 50-75 years. Int Urogynecol J Pelvic J. 2000;11:9-4. https://doi.org/10.1007/PL00004023
Hutchinson-Colas J, Segal S. Genitourinary syndrome of menopause and the use of laser therapy. Maturitas. 2015;82:342-5. https://doi.org/10.1016/j.maturitas.2015.08.001
Jackson SL, Boyko EJ, Scholes D, Abraham L, Gupta K, Fihn SD. Predictors of urinary tract infection after menopause: A prospective study. Am J Med. 2004;117:903-11. https://doi.org/10.1016/j.amjmed.2004.07.045
Oskay UY, Beji NK, Yalcin O. A study on urogenital complaints of postmenopausal women aged 50 and over. Acta Obstet Gynecol Scand. 2005;84:72-8. https://doi.org/10.1111/j.0001-6349.2005.00645.x
Pastore LM, Carter RA, Hulka BS, Wells E. Self-reported urogenital symptoms in postmenopausal women: Women’s Health Initiative. Maturitas. 2004;10:292-303. https://doi.org/10.1016/j.maturitas.2004.06.019
Espitia-De La Hoz FJ, Orozco-Gallego H. Estriol vs estrógenos conjugados de origen equino en el tratamiento del síndrome genitourinario de la menopausia. Ginecol Obstet Mex. 2018;86:117-126. https://doi.org/10.24245/gom.v86i2.1881
Nappi RE, Palacios S, Panay N, Particco M, Krychman ML. Vulvar and vaginal atrophy in four European countries: Evidence from the European REVIVE Survey. Climacteric. 2016;19:188-97. https://doi.org/10.3109/13697137.2015.1107039
Labrie F, Archer DF, Koltun W, Vachon A, Young D, Frenette L, et al. Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause. Menopause. 2016;23:243-56. https://doi.org/10.1097/GME.0000000000000571
Nappi RE, Kokot-Kierepa M. Vaginal Health: Insights, Views & Attitudes (VIVA) - Results from an international survey. Climacteric. 2012;15:36-44. https://doi.org/10.3109/13697137.2011.647840
Kagan R, Rivera E. Restoring vaginal function in postmenopausal women with genitourinary syndrome of menopause. Menopause. 2018;25:106-8. https://doi.org/10.1097/GME.0000000000000958
Ibe C, Simon JA. Vulvovaginal atrophy: Current and future therapies (CME). J Sex Med. 2010;7:1042-50. https://doi.org/10.1111/j.1743-6109.2009.01692.x
Huang KE. Menopause perspectives and treatment of Asian women. Semin Reprod Med. 2010;28:396-403. https://doi.org/10.1055/s-0030-1262899
Espitia-De La Hoz FJ, Orozco Gallego H, Echeverri Ocampo LM. Terapia hormonal y no hormonal en la vaginitis atrófica posmenopáusica: cura y satisfacción a mediano y a largo plazo de los síntomas. Rev. Col. de Menopausia. 2016;22:8-17.
How to Cite
Downloads
Downloads
Published
Issue
Section
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
